KRAS and colorectal carcinoma: A Russian study by Volkov et al.,9 in turn, reported a lower frequency (4.73%) of MAP in KRAS‐G12C CRC cases, which may be due to a higher frequency of KRAS‐G12C mutations in the Russian population compared to others and/or the existence of other common GPVs in the Russian population that were not included in their initial screening (Table 4).